BioHarvest Sciences (NASDAQ:BHST – Get Free Report) is projected to release its earnings data before the market opens on Monday, March 31st. Analysts expect BioHarvest Sciences to post earnings of ($0.12) per share and revenue of $7.24 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
BioHarvest Sciences Trading Up 1.6 %
Shares of BHST stock opened at $6.55 on Friday. BioHarvest Sciences has a 52 week low of $6.53 and a 52 week high of $7.38. The stock’s 50 day moving average is $5.65. The firm has a market cap of $107.58 million, a P/E ratio of -5.24 and a beta of 2.27.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the stock. Maxim Group assumed coverage on shares of BioHarvest Sciences in a research note on Wednesday, December 18th. They issued a “buy” rating and a $12.00 price target for the company. HC Wainwright initiated coverage on BioHarvest Sciences in a research report on Friday, December 6th. They issued a “buy” rating and a $14.00 target price for the company.
BioHarvest Sciences Company Profile
BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.
Featured Stories
- Five stocks we like better than BioHarvest Sciences
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- High Flyers: 3 Natural Gas Stocks for March 2022
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Differences Between Momentum Investing and Long Term Investing
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.